Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$6.72M Sell
52,100
-5,600
-10% -$734K 0.01% 1760
2014
Q2
$7.67M Buy
57,700
+55,600
+2,648% +$7.29M 0.01% 1571
2014
Q1
$275K Hold
2,100
﹤0.01% 4844
2013
Q4
$273K Sell
2,100
-1,300
-38% -$162K ﹤0.01% 4956
2013
Q3
$409K Sell
3,400
-200
-6% -$23.7K ﹤0.01% 4371
2013
Q2
$415K Buy
+3,600
New +$410K ﹤0.01% 4283

Other funds holding PX

UBS's PX Position: Q3 2014 in Review

UBS increased its Praxair Inc (PX) stake by 6.3% in Q3 2014, buying an estimated $2.3M and bringing the position to 297,798 shares worth $38.4M. The position accounts for 0.03% of the portfolio, ranked #615.

UBS first reported a position in PX in Q2 2013 and has held it in 6 quarters since. The position peaked at $40.4M in Q3 2013. 886 funds tracked by Wall St. Rank hold PX as of Q3 2014.

  • UBS held 297,798 shares of Praxair Inc worth $38.4M as of Q3 2014.
  • UBS bought 17,559 Praxair Inc shares in Q3 2014, an estimated $2.3M.
  • Praxair Inc made up 0.03% of UBS's portfolio in Q3 2014, its #615 holding.
  • UBS first reported a position in Praxair Inc in Q2 2013 and has held it in 6 quarters since.
  • UBS's Praxair Inc position peaked at $40.4M in Q3 2013.
  • 886 funds tracked by Wall St. Rank held Praxair Inc as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.